Appian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations
First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle BERLIN, Oct. 28, 2026 /PRNewswire/ -- Appian (Nasdaq: APPN) and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution. The new...
Covered in this story
Call it yourself
No calls on $APPN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Appian Corp Class a →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.